The Enforcement Directorate (ED) has summoned legal counsel for Care Health Insurance (formerly Religare Health) concerning advice on employee stock ownership plans (ESOPs) issued to former Religare Enterprises chairperson Rashmi Saluja. This action raises questions about regulatory compliance and could influence investor sentiment regarding Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares, particularly given Religare's significant stake in Care.
Mumbai – The Enforcement Directorate (ED), India's premier financial crime investigation agency, has issued summons to senior counsel Arvind Datar concerning his legal counsel provided to Care Health Insurance regarding the issuance of Employee Stock Ownership Plans (ESOPs) to Rashmi Saluja, the former chairperson of Religare Enterprises. Religare Enterprises holds a substantial 62.98% stake in Care Health Insurance, making this investigation particularly relevant to the valuation and future prospects of Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares.
The core of the ED's investigation centers on whether the issuance of these ESOPs complied with all applicable regulations. The agency is scrutinizing legal opinions provided, with potential questioning of former IRDAI (Insurance Regulatory and Development Authority of India) chairman, Hari Narayan, who also offered counsel on the matter. This regulatory scrutiny adds a layer of uncertainty for investors in the unlisted shares of Care Health Insurance.
The backdrop to this investigation involves the departure of Rashmi Saluja from Religare Enterprises in February, following shareholder opposition to her re-appointment. This concluded an extended legal dispute with the Burman family, the largest shareholders of Religare, who subsequently assumed control of Religare as its new promoter. The Burman family's involvement and the change in leadership could signal strategic shifts within Religare that indirectly affect Care Health Insurance.
According to sources, Arvind Datar has asserted to ED officials that summoning lawyers for investigations involving their clients sets a problematic precedent, citing professional privilege that protects the disclosure of legal advice.
The controversy surrounding the ESOPs began in 2019 when Care Health appointed Saluja as its non-executive chairperson. In 2021, it sought IRDAI approval to grant her ESOPs. However, IRDAI rejected the proposal in May 2022, arguing that Saluja's non-executive role was akin to that of a non-executive director, limiting the permissibility of such compensation. Care Health then sought opinions from both Datar and Narayan, who advised that ESOPs could be issued since Saluja was also an employee of Religare, holding an executive chairperson position there.
Based on this advice, Care Health allotted 22,700,000 ESOPs to Saluja. However, in 2024, IRDAI directed Care Health to buy back 7,569,000 of these shares at the original price of ₹45.32 per share, citing regulatory violations. All unused ESOPs were also ordered to be cancelled. The regulator's intervention underscores its commitment to upholding governance standards within the insurance sector.
While the ED investigation introduces short-term uncertainty, it also highlights the importance of regulatory adherence and transparent governance practices within Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares. For potential investors in unlisted shares, due diligence and a thorough understanding of the company's regulatory environment are crucial. As the situation unfolds, stakeholders will be keenly watching for any impact on Care Health Insurance's operational strategies and financial health. The long-term stability and growth potential of the company will likely depend on its ability to navigate these challenges effectively and reinforce investor confidence through sound corporate governance. Any positive resolution and demonstration of ethical business practices could significantly bolster the company's attractiveness in the unlisted market.
